Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ExSight Ventures is an early-stage venture capital firm established to address the funding gap for life science companies, particularly in ophthalmology. Founded in the United States, the firm focuses on innovative diagnostic and treatment solutions for eye care. The firm recognizes the critical need for capital in this sector and aims to support companies that are developing breakthrough technologies.
Currently, ExSight Ventures manages a portfolio of nine companies, all of which are engaged in the ophthalmic space. The firm emphasizes capital-efficient investments that can drive significant value creation. Their team comprises experienced professionals with backgrounds in law and medicine, enhancing their ability to evaluate and support investments in this specialized field.
ExSight Ventures concentrates its investments on early-stage companies within the biotechnology, medical devices, pharmaceuticals, and software solutions sectors, specifically related to ophthalmology. The firm targets funding rounds from pre-seed to Series B, ensuring that they engage with companies at various stages of development. Their investment strategy prioritizes capital-efficient opportunities that promise substantial value creation.
The firm’s investment thesis underscores the importance of domain expertise in ophthalmology, which allows them to identify and support breakthrough technologies aimed at diagnosing and treating vision diseases. This focus on specialized knowledge positions ExSight Ventures as a key player in the ophthalmic investment landscape.
ExSight Ventures has invested in nine transformative companies within the ophthalmic sector. While specific names and descriptions of these portfolio companies are not disclosed, the firm’s focus on innovative solutions in eye care indicates a commitment to supporting technologies that address significant challenges in vision health.
The portfolio reflects a diverse range of investments across biotechnology, medical devices, and software solutions, all aimed at enhancing patient outcomes in ophthalmology. This strategic selection of companies showcases ExSight Ventures' dedication to fostering advancements in eye care.
James C. Murray, J.D. - Partner. James has a legal background and extensive experience in venture capital, focusing on investments in life sciences and healthcare.
Dr. Michael Nissen - Partner. Dr. Nissen brings a wealth of medical expertise to the firm, having worked in various capacities within the healthcare sector.
Dr. Firas M. Rahhal - Partner. Dr. Rahhal has a strong background in ophthalmology and medical device innovation, contributing to the firm's focus on breakthrough technologies in eye care.
To pitch ExSight Ventures, founders should utilize the contact form available on their website. It is advisable to include a concise overview of the business model, market opportunity, and team background in the pitch deck. Response times may vary, and warm introductions are preferred but not mandatory.
What are ExSight Ventures' investment criteria?
ExSight Ventures invests in early-stage companies within the biotechnology, medical devices, pharmaceuticals, and software solutions sectors, specifically targeting ophthalmology. They focus on capital-efficient investments that can drive significant value creation.
How can I pitch to ExSight Ventures?
Founders interested in pitching to ExSight Ventures should visit their website at ExSight Ventures. Specific email addresses for pitches are not provided, but the website serves as the primary contact point.
What makes ExSight Ventures different from other VC firms?
ExSight Ventures specializes exclusively in the ophthalmic sector, addressing a critical funding gap for life science companies. Their emphasis on domain expertise in ophthalmology allows them to identify and support breakthrough technologies effectively.
What is the geographic focus of ExSight Ventures?
The firm primarily invests in companies based in the United States, concentrating on the ophthalmic market.
What is the typical check size for investments?
While specific check sizes are not disclosed, ExSight Ventures invests in early-stage funding rounds, which typically range from pre-seed to Series B.
What kind of support do portfolio companies receive?
ExSight Ventures provides operational support and strategic guidance to its portfolio companies, leveraging the team's expertise in law and medicine to enhance business development and growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.